Get the Stockscreener App
24.17
0.50%
0.12
After Hours:
24.17
Elanco Animal Health Inc stock is traded at $24.17, with a volume of 4.51M.
It is up +0.50% in the last 24 hours and up +12.79% over the past month.
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, poultry, and swine production.
See More
Previous Close:
$24.05
Open:
$24.27
24h Volume:
4.51M
Relative Volume:
0.74
Market Cap:
$12.07B
Revenue:
$4.89B
Net Income/Loss:
$-242.00M
P/E Ratio:
-49.43
EPS:
-0.489
Net Cash Flow:
$315.00M
1W Performance:
+2.29%
1M Performance:
+12.79%
6M Performance:
+13.53%
1Y Performance:
+70.57%
1-Day Range:
$24.00
$24.41
1-Week Range:
$22.76
$24.68
52-Week Range:
$13.15
$27.72
Elanco Animal Health Inc Stock (ELAN) Company Profile
Name
Elanco Animal Health Inc
Sector
Phone
877-352-6261
Address
450 ELANCO CIRCLE, INDIANAPOLIS
Compare ELAN vs TAK, TEVA, HLN, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ELAN
Elanco Animal Health Inc
|
24.17 | 12.07B | 4.89B | -242.00M | 315.00M | -0.489 |
TAK
Takeda Pharmaceutical Co Adr
|
15.91 | 50.27B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.63 | 40.32B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.13 | 40.31B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
79.57 | 33.36B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
545.96 | 23.17B | 3.17B | 1.29B | 1.01B | 27.09 |
Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-15-26 | Initiated | Citigroup | Buy |
| Jan-22-26 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-09-25 | Initiated | Barclays | Overweight |
| Nov-21-25 | Initiated | KeyBanc Capital Markets | Overweight |
| Nov-19-25 | Upgrade | Argus | Hold → Buy |
| Oct-07-25 | Upgrade | JP Morgan | Neutral → Overweight |
| Jul-17-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Jun-26-25 | Upgrade | William Blair | Mkt Perform → Outperform |
| Dec-09-24 | Initiated | UBS | Buy |
| Dec-02-24 | Initiated | Leerink Partners | Market Perform |
| Sep-19-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-05-24 | Upgrade | Stifel | Hold → Buy |
| Dec-19-23 | Initiated | Jefferies | Buy |
| Dec-15-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Dec-07-23 | Initiated | Exane BNP Paribas | Outperform |
| Apr-20-23 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-18-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Aug-16-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-21-22 | Downgrade | Goldman | Buy → Sell |
| Jul-12-22 | Initiated | Piper Sandler | Neutral |
| Nov-18-21 | Initiated | Morgan Stanley | Overweight |
| Oct-28-21 | Downgrade | Stifel | Buy → Hold |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jun-15-21 | Upgrade | Cleveland Research | Underperform → Neutral |
| May-11-21 | Upgrade | Barclays | Underweight → Equal Weight |
| May-11-21 | Upgrade | Gabelli & Co | Hold → Buy |
| Apr-15-21 | Initiated | Stifel | Buy |
| Mar-22-21 | Downgrade | Gabelli & Co | Buy → Hold |
| Feb-26-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Dec-09-20 | Downgrade | Argus | Buy → Hold |
| Nov-09-20 | Downgrade | Barclays | Overweight → Underweight |
| Aug-20-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-13-20 | Resumed | Credit Suisse | Neutral |
| Aug-04-20 | Resumed | Goldman | Buy |
| Jul-27-20 | Downgrade | Cleveland Research | Neutral → Underperform |
| Apr-02-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-10-20 | Initiated | Raymond James | Mkt Perform |
| Dec-19-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Nov-07-19 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-23-19 | Initiated | Barclays | Overweight |
| Aug-26-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Aug-15-19 | Upgrade | UBS | Sell → Neutral |
| May-23-19 | Initiated | Guggenheim | Neutral |
| Mar-18-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Mar-13-19 | Resumed | Morgan Stanley | Equal-Weight |
| Feb-12-19 | Initiated | William Blair | Mkt Perform |
| Jan-23-19 | Initiated | UBS | Sell |
| Jan-15-19 | Initiated | Argus | Buy |
| Oct-15-18 | Initiated | Morgan Stanley | Equal-Weight |
View All
Elanco Animal Health Inc Stock (ELAN) Latest News
Elanco Animal Health Incorporated $ELAN Position Reduced by Black Creek Investment Management Inc. - MarketBeat
Private Management Group Inc. Reduces Stake in Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Animal Health Q1 earnings call highlights - MSN
Brandes Investment Partners LP Has $95.09 Million Position in Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Animal Health Inc (ELAN) Shares Surge 3.5% -- What GF Sco - GuruFocus
Norges Bank Makes New $32.42 Million Investment in Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Animal Health Incorporated $ELAN Shares Sold by Bank of New York Mellon Corp - MarketBeat
Elanco Animal Health (ELAN) Stock Analysis: A 26% Upside Potential in the Healthcare Sector - DirectorsTalk Interviews
Clearbridge Investments LLC Has $128.37 Million Stock Position in Elanco Animal Health Incorporated $ELAN - MarketBeat
Harvest Fund Management Co. Ltd Has $366,000 Stock Holdings in Elanco Animal Health Incorporated $ELAN - MarketBeat
TD Asset Management Inc Purchases 516,628 Shares of Elanco Animal Health Incorporated $ELAN - MarketBeat
Jim Cramer Recommends Elanco Over Zoetis - Insider Monkey
Is Elanco’s Big Rally Still Worth Watching After Its Sharp Climb? - Kalkine Media
Earnings call transcript: Elanco Animal Health Q1 2026 surpasses expectations with strong growth - Investing.com
Is It Too Late To Consider Elanco Animal Health (ELAN) After Its Strong 1 Year Rally? - Yahoo Finance
Elanco Animal Health Commits to Supporting U.S. Livestock Producers and Pet Owners in Fight Against New World Screwworm - CSRwire
Elanco offers treatments for New World screwworm in U.S. livestock By Investing.com - Investing.com Canada
Elanco Animal HealthOffers Treatment Options For Livestock And Pets Against New World Screwworm - TradingView
Elanco Animal Health Incorporated $ELAN Shares Bought by Bowen Hanes & Co. Inc. - MarketBeat
Elanco Animal Health Inc (ELAN) Stock Up 4.0% but GF Value Says Overvalued -- GF Score: 66/100 - GuruFocus
Survey: Pet owners maintain health spending despite rising costs - PetfoodIndustry
Jim Cramer Says He Feels 'Something Not Well' At Zoetis, Names A Rival As His Pick - Benzinga
U.S. pet owners cut dining out before pet care, Elanco finds - Stock Titan
Peak Retirement Planning Inc. Acquires Shares of 121,770 Elanco Animal Health Incorporated $ELAN - MarketBeat
Geode Capital Management LLC Buys 640,098 Shares of Elanco Animal Health Incorporated $ELAN - MarketBeat
BNP Paribas Financial Markets Purchases 2,193,391 Shares of Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco (ELAN) CFO granted new deferred stock units under compensation plan - Stock Titan
Elanco (ELAN) officer Rajeev Modi receives deferred stock unit grant - Stock Titan
Elanco (ELAN) CEO Jeffrey Simmons granted new deferred stock units - Stock Titan
Elanco (ELAN) Q1 2026 Earnings Transcript - AOL.com
Legal & General Group Plc Has $17.68 Million Stock Position in Elanco Animal Health Incorporated $ELAN - MarketBeat
A Look At Elanco (ELAN) Valuation After Early Befrena Launch And Renewed Investor Optimism - Yahoo Finance
Elanco (ELAN) Is Up 9.8% After Launching Befrena, Its Second USDA-Approved Pet Biologic - Yahoo Finance
EBIT per share of Elanco Animal Health, Inc. – LS:A2N6BH - TradingView
Barclays Maintains Elanco Animal Health(ELAN.US) With Buy Rating, Maintains Target Price $30 - Moomoo
Ribbon cut on $200 million Elanco animal health campus - MSN
Jupiter Asset Management Ltd. Trims Stake in Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Shareholders Back Board, Auditor and Executive Pay - The Globe and Mail
Jackson Creek Investment Advisors LLC Buys Shares of 65,370 Elanco Animal Health Incorporated $ELAN - MarketBeat
Royce & Associates LP Sells 107,638 Shares of Elanco Animal Health Incorporated $ELAN - MarketBeat
Northwestern Mutual Wealth Management Co. Grows Position in Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Animal Health 2026 Shareholder Meeting Results: Board Elections and Executive Compensation Vote - Minichart
A Look at Elanco Animal Health Inc (ELAN) After 3.8% Gain -- GF Value $15.53 vs Price $23.69 - GuruFocus
Elanco (NYSE: ELAN) investors reelect board and ratify 2026 auditor - Stock Titan
Monumental Public-Private Initiative Forms to Permanently Close America’s Protein Gap - CSRwire
58,758 Shares in Elanco Animal Health Incorporated $ELAN Acquired by Williamson Legacy Group LLC - MarketBeat
A Look at Elanco Animal Health Inc (ELAN) After 5.0% Gain -- GF Value $15.53 vs Price $22.82 - GuruFocus
Board member at Elanco (NYSE: ELAN) granted new equity awards - Stock Titan
Elanco (NYSE: ELAN) director receives deferred and restricted stock units - Stock Titan
Elanco Animal Health (ELAN) director granted new equity awards - Stock Titan
[Form 4] Elanco Animal Health Inc Insider Trading Activity - Stock Titan
Elanco Animal Health Inc Stock (ELAN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.45%
1.04%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):